Literature DB >> 18852711

Home blood pressure monitoring: a new standard method for monitoring hypertension control in treated patients.

Thomas G Pickering1.   

Abstract

Inadequate blood pressure (BP) control in patients with treated hypertension can be influenced by patient behavior, the inaccuracy of BP measurement in the clinical setting, and the fact that no single class of medication is universally effective. Home BP monitoring (HBPM) enables accurate measurement of BP and has been recommended (by multiple societies and associations) for the diagnosis of hypertension and the evaluation of antihypertensive treatment. Although HBPM is thought to improve BP control as a result of patients' increased adherence to their medication, this improvement is limited. Green et al. have shown that HBPM in combination with regular internet correspondence with a medical professional is a highly effective therapeutic strategy for BP control, possibly because this strategy is associated with an increase in number of prescriptions. This strategy should, therefore, be routinely used in the management of patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852711     DOI: 10.1038/ncpcardio1374

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  8 in total

Review 1.  Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association.

Authors:  Lora E Burke; Jun Ma; Kristen M J Azar; Gary G Bennett; Eric D Peterson; Yaguang Zheng; William Riley; Janna Stephens; Svati H Shah; Brian Suffoletto; Tanya N Turan; Bonnie Spring; Julia Steinberger; Charlene C Quinn
Journal:  Circulation       Date:  2015-08-13       Impact factor: 29.690

2.  [Prevention of therapeutic inertia in the treatment of arterial hypertension by using a program of home blood pressure monitoring].

Authors:  Emilio Márquez Contreras; José Luis Martín de Pablos; Jacinto Espinosa García; José Joaquín Casado Martínez; Eugenio Sanchez López; José Escribano
Journal:  Aten Primaria       Date:  2011-10-20       Impact factor: 1.137

3.  Relationship of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension.

Authors:  Tonya L Breaux-Shropshire; Kathleen C Brown; Erica R Pryor; Elizabeth H Maples
Journal:  Workplace Health Saf       Date:  2012-07       Impact factor: 1.413

4.  Prevalence of blood pressure self-monitoring, medication adherence, self-efficacy, stage of change, and blood pressure control among municipal workers with hypertension.

Authors:  Tonya L Breaux-Shropshire; Kathleen C Brown; Erica R Pryor; Elizabeth H Maples
Journal:  Workplace Health Saf       Date:  2012-06       Impact factor: 1.413

5.  The Trial Using Motivational Interviewing and Positive Affect and Self-Affirmation in African-Americans with Hypertension (TRIUMPH): from theory to clinical trial implementation.

Authors:  Carla Boutin-Foster; Ebony Scott; Anna Rodriguez; Rosio Ramos; Balavenkatesh Kanna; Walid Michelen; Mary Charlson; Gbenga Ogedegbe
Journal:  Contemp Clin Trials       Date:  2013-02-09       Impact factor: 2.226

Review 6.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

7.  Counseling African Americans to Control Hypertension (CAATCH) trial: a multi-level intervention to improve blood pressure control in hypertensive blacks.

Authors:  Gbenga Ogedegbe; Jonathan N Tobin; Senaida Fernandez; William Gerin; Marleny Diaz-Gloster; Andrea Cassells; Chamanara Khalida; Thomas Pickering; Antoinette Schoenthaler; Joseph Ravenell
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-05

8.  Urinary proteomics combined with home blood pressure telemonitoring for health care reform trial: rational and protocol.

Authors:  Lutgarde Thijs; Kei Asayama; Gladys E Maestre; Tine W Hansen; Luk Buyse; Dong-Mei Wei; Jesus D Melgarejo; Jana Brguljan-Hitij; Hao-Min Cheng; Fabio de Souza; Natasza Gilis-Malinowska; Kalina Kawecka-Jaszcz; Carina Mels; Gontse Mokwatsi; Elisabeth S Muxfeldt; Krzysztof Narkiewicz; Augustine N Odili; Marek Rajzer; Aletta E Schutte; Katarzyna Stolarz-Skrzypek; Yi-Wen Tsai; Thomas Vanassche; Raymond Vanholder; Zhen-Yu Zhang; Peter Verhamme; Ruan Kruger; Harald Mischak; Jan A Staessen
Journal:  Blood Press       Date:  2021-08-30       Impact factor: 1.771

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.